171 related articles for article (PubMed ID: 18309132)
1. Highly active antiretroviral therapy use and HIV transmission risk behaviors among individuals who are HIV infected and were recently released from jail.
Clements-Nolle K; Marx R; Pendo M; Loughran E; Estes M; Katz M
Am J Public Health; 2008 Apr; 98(4):661-6. PubMed ID: 18309132
[TBL] [Abstract][Full Text] [Related]
2. An ecosystem-based intervention to reduce HIV transmission risk and increase medication adherence among inmates being released to the community.
Reznick OG; McCartney K; Gregorich SE; Zack B; Feaster DJ
J Correct Health Care; 2013 Jul; 19(3):178-93. PubMed ID: 23657796
[TBL] [Abstract][Full Text] [Related]
3. Predictors of reincarceration and disease progression among released HIV-infected inmates.
Baillargeon J; Giordano TP; Harzke AJ; Spaulding AC; Wu ZH; Grady JJ; Baillargeon G; Paar DP
AIDS Patient Care STDS; 2010 Jun; 24(6):389-94. PubMed ID: 20565323
[TBL] [Abstract][Full Text] [Related]
4. Predictors of highly active antiretroviral therapy utilization for behaviorally HIV-1-infected youth: impact of adult versus pediatric clinical care site.
Agwu AL; Siberry GK; Ellen J; Fleishman JA; Rutstein R; Gaur AH; Korthuis PT; Warford R; Spector SA; Gebo KA
J Adolesc Health; 2012 May; 50(5):471-7. PubMed ID: 22525110
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV.
Castilla J; Del Romero J; Hernando V; Marincovich B; García S; Rodríguez C
J Acquir Immune Defic Syndr; 2005 Sep; 40(1):96-101. PubMed ID: 16123689
[TBL] [Abstract][Full Text] [Related]
6. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
7. Health and health behaviors in HIV-infected jail inmates, 1999 and 2005.
White MC; Tulsky JP; Estes M; Jamison R; Long HL
AIDS Patient Care STDS; 2008 Mar; 22(3):221-31. PubMed ID: 18338943
[TBL] [Abstract][Full Text] [Related]
8. Unexpected high rate of wild-type HIV-1 genotype among inmates failing antiretroviral therapy.
Pontali E; Ventura A; Bruzzone B; Icardi G; Ferrari F
HIV Clin Trials; 2008; 9(5):341-7. PubMed ID: 18977723
[TBL] [Abstract][Full Text] [Related]
9. Does antiretroviral therapy prevent HIV transmission to sexual partners?
Lalani T; Hicks C
Curr HIV/AIDS Rep; 2007 May; 4(2):80-5. PubMed ID: 17547829
[TBL] [Abstract][Full Text] [Related]
10. Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders.
Machtinger EL; Haberer JE; Wilson TC; Weiss DS
AIDS Behav; 2012 Nov; 16(8):2160-70. PubMed ID: 22426597
[TBL] [Abstract][Full Text] [Related]
11. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
[TBL] [Abstract][Full Text] [Related]
12. HIV transmission from mother to child--HAART compared with dual therapy.
Theron G; Nellensteijn M; Theron A; Louw J
S Afr Med J; 2009 Oct; 99(10):717, 720. PubMed ID: 20128268
[No Abstract] [Full Text] [Related]
13. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community.
Springer SA; Pesanti E; Hodges J; Macura T; Doros G; Altice FL
Clin Infect Dis; 2004 Jun; 38(12):1754-60. PubMed ID: 15227623
[TBL] [Abstract][Full Text] [Related]
14. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
[TBL] [Abstract][Full Text] [Related]
15. The impact of highly active antiretroviral therapy on high-risk behaviour of HIV-infected patients in sub-Saharan Africa.
Kaye DK; Kakaire O; Osinde MO; Lule JC; Kakande N
J Infect Dev Ctries; 2013 Jun; 7(6):436-47. PubMed ID: 23771287
[TBL] [Abstract][Full Text] [Related]
16. Recidivism in HIV-infected incarcerated adults: influence of the lack of a high school education.
Marlow E; White MC; Tulsky JP; Estes M; Menendez E
J Urban Health; 2008 Jul; 85(4):585-95. PubMed ID: 18418714
[TBL] [Abstract][Full Text] [Related]
17. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
18. Jail inmates and HIV care: provision of antiretroviral therapy and Pneumocystis carinii pneumonia prophylaxis.
White MC; Mehrotra A; Menendez E; Estes M; Goldenson J; Tulsky JP
Int J STD AIDS; 2001 Jun; 12(6):380-5. PubMed ID: 11368819
[TBL] [Abstract][Full Text] [Related]
19. [HIV risk behavior in prison and factors associated with reincarceration of injection drug users].
Rotily M; Delorme C; Galinier A; Escaffre N; Moatti JP
Presse Med; 2000 Sep; 29(28):1549-56. PubMed ID: 11072370
[TBL] [Abstract][Full Text] [Related]
20. HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review.
Lambert CT; Sandesara PB; Hirsh B; Shaw LJ; Lewis W; Quyyumi AA; Schinazi RF; Post WS; Sperling L
HIV Med; 2016 Jun; 17(6):411-24. PubMed ID: 26611380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
